Home > Insider Trading > Filing (0001299130-23-000040)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1299130	Pacific Biosciences Of California Inc.	PACB	Laboratory Analytical Instruments (3826)	161590339

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1707477	Mark Oene Van	Pacific Biosciences Of California, Inc., 1305 O'Brien Drive Menlo Park CA 94025	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-02	328,500	$0.00	972,139	No	4	A	Direct
Common Stock	Disposition	2023-03-03	6,268	$9.49	965,871	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date.
Includes 2,831 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan.
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
This sale price represents the weighted average sale price of the shares sold ranging from $9.24 to $9.71 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.